Korean Pharmaceutical Industry (002422.SZ) subsidiary will announce multiple innovative drug research results at the American Clinical Oncology Society Annual Meeting in 2026.

Zhtng Cijng app xn, k ln yoy (002422.SZ) fb gnggo, gngs jnr huxn, gngs kngg zs cngs schun k ln bti shngw yyo gfn yuxin gngs (jinchngk ln bti) jing y 2026 nin 5 yu 29 r zh 6 yu 2 r zi migu ylnu zhou zhjig sh jxng de 2026 nin migu lnchng zhnglixu hu (ASCO) nin hu shng gngb duxing k ln bti zhdo de lnchng ynji chnggu, qzhng zhngxing rn zyng x xbo guntng 2 (TROP2) kngtingnx guw (ADC) l kng sh tu zh dn kng (sac-TMT) (jiti li), xn ydi xunz xzhun guchng zhng chngpi (RET) yzh j f m sun ln bti n (A400/EP0031) ling xing zhc ynji rxun zhunyng xng fi xio xbo fii kutu bogo zhuncng.